William S. Mayo, D.O. has partnered to read digital retinal images for Retasure™ by Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. Dr. Mayo is the president of the Mississippi Eye, Ear, Nose and Throat Society and is a double board certified ophthalmologist that practices in Oxford, Mississippi.
(PRWEB) March 19, 2009 -- William S. Mayo, D.O. has partnered to read digital retinal images for Retasure™ by Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. Dr. Mayo is the president of the Mississippi Eye, Ear, Nose and Throat Society and is a double board certified ophthalmologist that practices in Oxford, Mississippi.
The Retasure™ solution developed by Digital Healthcare provides a simple, affordable, and non-invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Certified readers, like Dr. Mayo, use the ophthalmic specific review tools in Retasure™ to assess the images and consult with the primary care physician.
"The incidence of Diabetic Eye Disease in our population is growing exponentially. Early diagnosis and treatment of diabetic retinopathy will prevent vision loss in our patients and will allow them to lead productive and independent lives. Examination of the retina is key to preventing vision loss due to diabetic retinopathy. The most important health care priority is the delivery of quality medical care. Retasure will help you help your patients." states Dr. Mayo.
Scott Sanner, Vice President of North American Operations for Digital Healthcare, agrees. "The National Eye Institute states that diabetic retinopathy is the leading cause of blindness among working age adults in America," he says, "but fewer than half of all diabetic patients are assessed annually for retinopathy, despite the high frequency of this complication."
Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation. This FDA-approved technology is used by a broad range of doctors and facilities throughout the United States and the United Kingdom, including leading hospitals and research centers, primary care groups, private ophthalmology and optometry groups, family practice residency centers, and internal, multi-specialty and endocrinology groups. More than a million patients around the world have received a retinal health assessment using Digital Healthcare software.
For additional information, please visit www.retasure.com
Contact: Scott Sanner (866) 539-4213
# # #
Read the full story at http://www.prweb.com/releases/2009/03/prweb2246934.htm.
Copyright©2009 Vocus, Inc.
All rights reserved